Form 4 Spyre Therapeutics, Inc. For: May 01 Filed by: Sloan Sheldon

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. COF
6. SMCI
7. GOOGL
8. RTX
9. TSLA
10. CRWV

Go back to Form 4 Spyre Therapeutics, Inc. For: May 01 Filed by: Sloan Sheldon

Spyre (SYRE) PT Raised to $107 at Stifel

May 5, 2026 4:26 PM EDT

Stifel analyst Alex Thompson raised the price target on Spyre (NASDAQ: SYRE) to $107.00 (from $92.00) while maintaining a Buy rating.

The analyst comments "Following best-in-class UC PoC data for SPY001 (a4B7), SYRE is well-positioned heading into additional PoC cohorts for... More